RNU6-113P

Across TCGA pan-cancer cohorts, RNU6-113P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-113P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU6-113P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-113P expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

THCA, UCEC, and SKCM are the cancer types where RNU6-113P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.171	0.929	<.001	81	view →
UCEC	OS	Tertile	All	0.810	0.930	.005	54	view →
SKCM	DFS	Tertile	II,III,IV	0.046	0.708	<.001	18	view →
KIRC	DFS	Tertile	IV	0.167	0.605	<.001	18	view →
LIHC	DFS	Tertile	All	0.149	0.529	.045	9	view →
GBM	DFS	Tertile	All	0.853	0.246	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-113P–THCA (OS)

Open the THCA breakdown →